As of January 2025, Nextgen Biomed has a market cap of $1.25M. This makes Nextgen Biomed the world's 33555th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.26M | -10.14% |
2023 | $2.52M | 102.87% |
2022 | $1.24M | -55.05% |
2021 | $2.76M | -41.87% |
2020 | $4.75M | 90466.04% |
2019 | $5.24K | -9.56% |
2018 | $5.80K | -0.34% |
2017 | $5.82K | 53.12% |
2016 | $3.80K | -57.62% |
2015 | $8.96K | -91.87% |
2014 | $110.21K | 67.47% |
2013 | $65.81K | -92.10% |
2012 | $832.54K | 388.37% |
2011 | $170.47K | -66.67% |
2010 | $511.41K | -70.50% |
2007 | $1.73M | -26.47% |
2006 | $2.36M | -2.67% |
2005 | $2.42M | 5.79% |
2004 | $2.29M | 97.21% |
2003 | $1.16M | 41.90% |
2002 | $818.20K | - |